Thyrotoxic hypokalemic periodic paralysis as the presenting symptom in a young Ashkenazi Jewish man.
Barski
Leonid
L
Department of Medicine F, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. lbarski@bgu.ac.il
Nevzorov
Roman
R
Lotkowitz
Alan
A
Shleyfer
Elena
E
Liel
Yair
Y
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D004630:Emergencies; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D020514:Hypokalemic Periodic Paralysis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics; D007585:Jews; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D011188:Potassium / Q000097:blood / Q000627:therapeutic use; D015995:Prevalence; D011433:Propranolol / Q000627:therapeutic use; D012008:Recurrence; D013971:Thyrotoxicosis / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D013956:Antithyroid Agents; D008713:Methimazole; D011433:Propranolol; D011188:Potassium